Medtronic discloses 15.7M Anteris AVR shares

Medtronic plc, as a 10% owner of Anteris Technologies Global Corp. (AVR), has filed an initial ownership report.

Accepted by SEC EDGAR 01/29/2026 - 04:11 PM EST

(High)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Medtronic plc, as a 10% owner of Anteris Technologies Global Corp. (AVR), has filed an initial ownership report. The filing shows indirect beneficial ownership of 15,652,173 shares of common stock, which are held through Covidien Group S.a.r.l. rather than directly by Medtronic.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Medtronic plc

Role 10% Owner

Type	Security	Shares	Price	Value
Holding	Common Stock	--	--	--

Holdings: Common Stock — 15,652,173 shares (Indirect, Held by Covidien Group S.a.r.l.)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Medtronic plc’s Form 3 filing for Anteris Technologies (AVR) show?

The Form 3 shows that Medtronic plc is a 10% owner of Anteris Technologies Global Corp., reporting indirect beneficial ownership of 15,652,173 common shares held through Covidien Group S.a.r.l. as of January 22, 2026.

How many Anteris Technologies (AVR) shares are reported in this Form 3?

The filing reports beneficial ownership of 15,652,173 shares of Anteris Technologies Global Corp. common stock. These shares are not held directly by Medtronic plc but are owned indirectly through Covidien Group S.a.r.l., as disclosed in the ownership table.

Is Medtronic plc a direct or indirect owner of Anteris Technologies (AVR) shares?

Medtronic plc is reported as an indirect owner of Anteris Technologies Global Corp. shares. The 15,652,173 common shares are held by Covidien Group S.a.r.l., with Medtronic identified as the reporting person and 10% owner in the Form 3 filing.

What is Covidien Group S.a.r.l.’s role in Medtronic’s Anteris (AVR) ownership?

Covidien Group S.a.r.l. is listed as the entity that actually holds the 15,652,173 Anteris Technologies Global Corp. common shares. Medtronic plc reports these shares as indirectly beneficially owned, reflecting its relationship to Covidien Group S.a.r.l.

Why did Medtronic plc file a Form 3 for Anteris Technologies (AVR)?

Medtronic plc filed Form 3 because it is a 10% owner of Anteris Technologies Global Corp. SEC rules require large shareholders to disclose their initial beneficial ownership, here showing 15,652,173 common shares held indirectly via Covidien Group S.a.r.l.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Medtronic plc

(Last)

(First)

(Middle)

BUILDING TWO

PARKMORE BUSINESS PARK WEST

(Street)

GALWAY

H91 4K49

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/22/2026

3. Issuer Name and Ticker or Trading Symbol
Anteris Technologies Global Corp. [ AVR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	15,652,173	I	Held by Covidien Group S.a.r.l.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

	/s/ Brian Sandstrom, Assistant Secretary	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR